what bmi qualifies for tirzepatide Efficacy of weight loss and it's comparative effectiveness to weight loss surgery in inflammatory bowel disease | Indian Journal of Gastroenterology Tirzepatide for Medical Weight Loss

Oral semaglutide 50mg daily led to approximately 15% weight loss over 68 weeks, matching what injectable Wegovy achieves

Blood pressure was also modestly reduced, average baseline blood pressure was 125mmHg, it reduces this by about 6mmHg, in line with other GLP1 medications and again this is beneficial for long term health

In line with the expected pharmacology, we observed that GIP(1-42) and GLP-1(7-36) potency for cAMP accumulation was dependent on receptor density and ranged from low pM at high expression levels to potency values approaching nM at low expression levels (Supplemental Table 1) (18)

Age Older individuals may take longer to notice benefits due to decreased absorption and metabolic rates

They consider factors such as hormonal imbalances , coexisting conditions, or persistent fatigue that may indicate underlying issues beyond weight

Its about using a known anti-inflammatory effect of these drugs at the lowest dose that meaningfully improves disease control